News & Advisories

In week ending October 11, local indicators for COVID-19 were elevated, but appeared to be dropping. Local indicators for influenza and respiratory syncytial virus (RSV) remained minimal. Regional laboratory surveillance most frequently detected rhinovirus and COVID-19 among clinical respiratory specimens. 1.0% of emergency department (ED) visits were attributable to COVID-19, fewer than 10 visits were attributable to influenza, and 0 visits were attributable to RSV. Kitsap

Viruses that cause respiratory illnesses (illnesses that affect our lungs and breathing) tend to spread more widely during fall and winter months. 

In week ending October 4, local indicators for COVID-19 were elevated, but hospitalizations remained low. Local indicators for influenza and respiratory syncytial virus (RSV) remained minimal.

In week ending September 20, local indicators for influenza and respiratory syncytial virus (RSV) remained minimal.

If you follow the news, you know there has been a lot of discussion around changing COVID-19 vaccine recommendations.  Here are a few key points to be aware of.

In week ending Aug. 23, local indicators for influenza and respiratory syncytial virus (RSV) remained minimal.

In week ending July 26, local indicators for influenza and respiratory syncytial virus (RSV) remained minimal.

BE AWARE that the CDC recommends everyone 6 months or older get 2024–2025 COVID-19 and flu vaccine. Co-administration of COVID-19, flu, and RSV vaccines is safe.

...

...

...